imatinib mesylate has been researched along with Lupus Nephritis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Anchordoquy, TJ; Brown, JM; Charkoftaki, G; Fogueri, U; Ibrahim, M; Joy, MS; Persaud, I; Roda, G; Thurman, JM; Tuey, S; Wempe, MF | 1 |
Harada, M; Hirakata, H; Igawa, T; Masutani, K; Miyake, K; Nakashima, H; Niiro, H; Sadanaga, A; Shimizu, S; Sugiyama, N | 1 |
Abbate, M; Corna, D; Remuzzi, G; Rottoli, D; Zanchi, C; Zoja, C | 1 |
Kameda, H | 1 |
1 review(s) available for imatinib mesylate and Lupus Nephritis
Article | Year |
---|---|
[Imatinib mesylate as a novel therapeutic drug for systemic rheumatic diseases].
Topics: Animals; Arthritis, Rheumatoid; Benzamides; Humans; Imatinib Mesylate; Lung Diseases, Interstitial; Lupus Nephritis; Piperazines; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Rheumatic Diseases; Signal Transduction | 2007 |
3 other study(ies) available for imatinib mesylate and Lupus Nephritis
Article | Year |
---|---|
An evaluation of a novel nanoformulation of imatinib mesylate in a mouse model of lupus nephritis.
Topics: Animals; Disease Models, Animal; Female; Humans; Imatinib Mesylate; Kidney; Lupus Nephritis; Male; Mice; Particle Size | 2022 |
Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
Topics: Animals; Antineoplastic Agents; Autoantibodies; Benzamides; Blood Urea Nitrogen; CD4-Positive T-Lymphocytes; Creatinine; DNA; Female; Glomerulonephritis; Imatinib Mesylate; Immunoglobulin G; Interferon-gamma; Lupus Nephritis; Lymphatic Diseases; Mice; Mice, Inbred MRL lpr; Piperazines; Platelet-Derived Growth Factor; Proteinuria; Pyrimidines; Salivary Glands; Severity of Illness Index; Spleen; Splenomegaly; Survival Analysis | 2005 |
Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease.
Topics: Actins; Animals; Antigens, Differentiation; Benzamides; Female; Fibroblasts; Imatinib Mesylate; Kidney; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Muscle, Smooth; Piperazines; Protein Kinase Inhibitors; Proteinuria; Pyrimidines; Receptors, Platelet-Derived Growth Factor | 2006 |